BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma

  March 31, 2025

   · 

  5 min read
• Press Releases

  QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

  March 31, 2025

   · 

  3 min read
• Press Releases

  ICON plc Schedules First Quarter 2025 Earnings Conference Call

  March 31, 2025

   · 

  2 min read
• Press Releases

  KalVista Pharmaceuticals to Present at 24th Annual Needham Virtual Healthcare Conference

  March 31, 2025

   · 

  2 min read
• Press Releases

  SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding

  March 31, 2025

   · 

  7 min read
• Press Releases

  Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025

  March 31, 2025

   · 

  10 min read
• Press Releases

  Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk

  March 31, 2025

   · 

  9 min read
• Press Releases

  Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer

  March 31, 2025

   · 

  6 min read
• Press Releases

  Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

  March 31, 2025

   · 

  12 min read
• Press Releases

  Late-Breaking Clinical Trial Presented at the American College of Cardiology Supports Low-Dose Colchicine, 0.5 mg to Treat Cardiovascular Disease by Reducing Progression of Coronary Plaque

  March 31, 2025

   · 

  6 min read